Lung morphogenesis begins with a ventral out-pouching of endodermally derived cells from the anterior foregut into the surrounding mesenchyme at E9 -9.5 1 in the mouse. Lung tubules are formed by branching morphogenesis as respiratory epithelial cells proliferate and differentiate to form the conducting airways. Thereafter, terminal airways sacculate and septate to form the alveoli typical of the peripheral lung. The ordered process mediating branching morphogenesis and the formation of the alveoli are regulated by the precise temporalspatial expression of many transcription factors, including Gata6, Ttf1, and forkhead transcription factors, including Foxa1, Foxa2, Foxj1, Foxf1, Foxp1, and Foxp2, that regulate gene expression and influence cell differentiation in the lung (1-6).
Lung morphogenesis begins with a ventral out-pouching of endodermally derived cells from the anterior foregut into the surrounding mesenchyme at E9 -9.5 1 in the mouse. Lung tubules are formed by branching morphogenesis as respiratory epithelial cells proliferate and differentiate to form the conducting airways. Thereafter, terminal airways sacculate and septate to form the alveoli typical of the peripheral lung. The ordered process mediating branching morphogenesis and the formation of the alveoli are regulated by the precise temporalspatial expression of many transcription factors, including Gata6, Ttf1, and forkhead transcription factors, including Foxa1, Foxa2, Foxj1, Foxf1, Foxp1, and Foxp2, that regulate gene expression and influence cell differentiation in the lung (1) (2) (3) (4) (5) (6) .
Foxa (previously termed HNF3) transcription factors comprise a subfamily of forkhead transcription factors that share Ͼ90% homology in the winged helix DNA binding domain. Likewise, the transactivation domains in the C-terminal and N-terminal regions of Foxa1 and Foxa2 share structural similarity (7, 8) . Foxa proteins are expressed primarily in endodermally derived tissues where they influence embryonic patterning, cell differentiation, and function (9) . The Foxa family includes Foxa1, Foxa2, and Foxa3 (previously termed HNF3␣, HNF3␤, and HNF3␥ respectively). Only Foxa1 and Foxa2 are expressed in the lung (10) . In mouse, Foxa2 is first expressed in the primitive streak at E6.5, shortly after the onset of gastrulation (11) . Thereafter, Foxa2 is present in the notochord, gut endoderm, and ventral midline of the central nervous system. Later in embryonic development, Foxa2 is detected in organs derived from the foregut endoderm and the hindgut endoderm (10 -12) , tissues of ectodermal and mesodermal origins, and endodermally derived epithelial cells in the lung (13) . Foxa1 mRNA is detected in the endoderm during the late primitive streak stage of development in the mice. Later in development, Foxa1 mRNA is observed in the ventral floor plate, notochord, and gut in a pattern similar to that in Foxa2 (10 -12, 14, 15) . In the lung, the temporal-spatial expression patterns of Foxa1 and Foxa2 are similar. Foxa1 and Foxa2 are present in the nuclei of epithelial cells from the onset of lung bud formation and in the respiratory epithelial cells lining conducting and peripheral airways of the mouse and human fetus (13, 16, 17) .
Null mutation of the Foxa2 gene in the mouse embryo inhibits formation of the notochord and endoderm before the onset of lung morphogenesis (18, 19) . Thus, the potential role of Foxa2 in lung formation and function could not be studied. Ectopic expression of Foxa2 in distal respiratory epithelial cells in the lungs of transgenic mice disrupts branching morphogenesis and arrests differentiation of peripheral epithelial cells, suggesting its potential role in lung formation (20) . Recent studies in which Foxa2 was conditionally deleted in the lung epithelial cells showed that Foxa2 is required for normal alveolarization and postnatal lung homeostasis but is not required for branching morphogenesis (21) . Despite the expression of Foxa1 throughout lung development, alterations in branching morphogenesis were not observed in
Foxa1
Ϫ/Ϫ mice. Foxa1 Ϫ/Ϫ mice survive after birth but generally die between postnatal days 2 and 14, exhibiting growth retardation and hypoglycemia (22, 23) .
The DNA binding domains of Foxa1 and Foxa2 are highly conserved and bind similar cis-acting elements. Because activation domains are also conserved, Foxa1 and Foxa2 may either compete or serve complementary roles at transcriptional targets (24 -26) . Because the pattern of their expression in the developing lung is similar, we hypothesized that Foxa1 and Foxa2 may play partially overlapping roles in lung morphogenesis (13, 16, 17) . To assess the potential roles of Foxa proteins in lung formation, Foxa1 Ϫ/Ϫ /Foxa2 ⌬/⌬ mice were produced in which both genes were deleted in respiratory epithelial cells in the mouse fetus.
EXPERIMENTAL PROCEDURES
Transgenic Constructs-Triple transgenic mice, SPC-rtT
LoxP/LoxP , were generated by crossing SPCrtTA
LoxP/LoxP and (tetO) 7 Cre Ϫ/tg mice as reported previously (21) . Doxycycline food was administered to the pregnant dam to induce recombination in epithelial cells of the fetal lung resulting in deletion of the Foxa2 gene (SPC-rtTA
LoxP/LoxP ), were generated by crossing SPC-rtTA
/Foxa2
LoxP/LoxP and Foxa1 Ϫ/ϩ . After doxycycline food was administered to the pregnant dam, the Foxa2 gene was selectively deleted in subsets of epithelial cells in the Foxa1 Ϫ/Ϫ lung. These mice are termed Foxa1
LoxP/LoxP . These genotypes were verified by PCR (21, 22) . Animal Use and Doxycycline Administration-Mice were housed in pathogen-free conditions in accordance with the Institutional Animal Care and Use Committee guidelines. Gestational age was determined by detection of the vaginal plug (as E0.5) and correlated with the length and weight of each pup at the time of sacrifice. Dams bearing transgenic pups were maintained on food containing doxycycline (625 mg/kg; Harlan Teklad, Madison, WI) from E0.
Histology, Immunohistochemistry, in Situ Hybridization, and Electron Microscopy-Fetal lungs were prepared for histology as described previously (27) . The antibodies used for immunohistochemistry were pro-SP-C (1:1000, rabbit polyclonal; AB3428, Chemicon), CCSP (1:7500, rabbit polyclonal; kindly provided by Dr. Barry Stripp, University of Pittsburgh), mature SP-B (1:1000, rabbit polyclonal; AB3426, Chemicon), thyroid transcription factor-1 (1:1000, rabbit polyclonal; generated in this lab), platelet endothelial cell adhesion molecule-1 (PECAM-1) (1:500, rat polyclonal; clone CD31, BD Pharmingen), ␣-smooth muscle actin (␣-SMA) (1:15,000, mouse monoclonal; clone 1A4, Sigma-Aldrich), Foxa2 (1:5000, rabbit polyclonal anti-rat Foxa2; generated in this laboratory) (13), Foxa1 (1:2000, guinea pig polyclonal antibody; generated in this laboratory), ␣-SMA (1:10,000, mouse monoclonal), and ␣-phosphohistone H3 (1:400, rabbit polyclonal, US Biological). The specificity of these Foxa1 and Foxa2 antibodies was discussed recently (13) . All experiments shown are representative of findings from at least two independent dams, generating at least four triple transgenic offspring that were compared with litter mates. In situ hybridization for Shh mRNA was performed by using 35 S-UTP and 35 S-CTP labeled riboprobes as described previously (28) . Electron microscopy was performed on lung tissue obtained from E15.5 and E18.5 Foxa1 Ϫ/Ϫ /Foxa2 ⌬/⌬ mice and litter mate controls after fixation in modified Karnovsky's fixative as described (20) .
RNA Isolation and Analysis-Lung RNAs from Foxa1 Ϫ/Ϫ /Foxa2
and age-matched control mice were prepared using a Rapid Total RNA isolation kit (Eppendorf-5Prime, Inc., Boulder, CO) following the manufacturer's specifications. RNA was treated with DNase at 37°C for 30 min. Lung cRNA was hybridized to the murine genome MOE430A (consisting of ϳ22,000 gene entries; Affymetrix Inc.) chips using the manufacturer's protocol. Affymetrix MicroArray Suite version 5.0 was used to scan and quantitate the gene chips using default scan settings. Normalization was performed using the Robust Multichip Average model that consists of three steps, namely background adjustment, quartile normalization, and summarization (29, 30) . Detection of differential expression was performed using Welch's approximate t test for mutant and control groups at a p value of Յ0.05. Additional filters for positive candidate selection included a minimum 1.5-fold change in absolute ratio and a minimum of two present calls by the Affymetrix algorithm in three samples.
DNase was removed by a DNase inactivation reagent (Ambion, Austin, TX) before cDNA synthesis. DNase-treated total lung RNA (0.5 g) was reverse transcribed and analyzed by real time PCR with the Smart Cycler System (Cepheid, Sunnyvale, CA). The relative concentration of each gene was normalized to the concentration of glyceraldehyde-3-phosphate dehydrogenase in each sample. Glyceraldehyde-3-phosphate dehydrogenase mRNA was quantitated using the primers 5Ј-CTTCACCACCATGGAGGAGGC-3Ј (5Ј) and 5Ј-GGCATGGACTGT-GGTCATGAG-3Ј (3Ј). The Shh primers were 5Ј-AATCTGCAACG-GAAGCGAGG-3Ј (5Ј) and 5Ј-AACAGCCAGGTGCCAATGTG-3Ј (3Ј). The Wnt7b primers were 5Ј-TCCAGATGGGGACAGAAGAACTCAG-3Ј and 5Ј-TCAGGGTGGGACATTTCCAGTG-3Ј (3Ј). The relative abundance of smooth muscle mRNAs was assessed with MOE430A RNA chips by hybridizing to lung mRNAs from control and Foxa1 Ϫ/Ϫ / Foxa2 ⌬/⌬ mice at E14.5 as discussed previously. Statistical Analysis of ␣-Phosphohistone-stained Cell Counting-Sections of lungs from control and Foxa1
⌬/⌬ mice were immunostained for ␣-phosphohistone H3, and the number of mitotic nuclei was assessed (stained cells/m 2 ) using Metamorph Imaging software (Universal Imaging Corporation). Excel software was used to carry out t test analysis.
RESULTS

Deletion of Both Foxa1 and Foxa2-To assess the efficiency of Cre-mediated Foxa2 gene deletion in the Foxa1
Ϫ/Ϫ /Foxa2
mice, Foxa2 immunostaining was assessed in the fetal mouse lung at E12.5, E15.5, and E18.5 ( Fig. 1 ). In control ( Fig. 1 , A, E, and I) and Foxa1 Ϫ/Ϫ mice ( Fig. 1 , B, F, and J), Foxa2 was detected in the nuclei of most pulmonary epithelial cells, including those lining the airways, and alveolar type II cells in peripheral saccules. In Foxa2 ⌬/⌬ and Foxa1 Ϫ/Ϫ /Foxa2 ⌬/⌬ mice, Foxa2 was absent in subsets of respiratory epithelial cells. As shown previously (21), Foxa2 staining was absent in most epithelial cells in both the conducting airways and the peripheral saccules in Foxa2 ⌬/⌬ mice at E18.5 ( Fig. 1K ). The extent of loss of Foxa2 staining in Foxa1 Ϫ/Ϫ /Foxa2 ⌬/⌬ mice was less than that observed in the Foxa1 ϩ/ϩ /Foxa2 ⌬/⌬ mice (21), indicating that the lack of Foxa1 may decrease the efficiency of Foxa2 gene targeting directed by the SP-C-rtTA, (tetO) 7 Cre system. Foxa1 was detected in nuclei of respiratory epithelial cells in both the proximal and peripheral regions of the lungs of control ( Fig. 2A) and Foxa2 ⌬/⌬ mice (Fig. 2C ). As expected, Foxa1 staining was absent in lungs from Foxa1 2D ). In Foxa1 Ϫ/Ϫ mice, deletion of Foxa1 resulted in increased level of Foxa2 mRNA (1.5-fold, n ϭ 3, p Ͻ 0.05) at E18.5, suggesting that Foxa2 may compensate for the loss of Foxa1 in lungs from the Foxa1 Ϫ/Ϫ mice. Similarly, Foxa1 mRNA was increased after the conditional deletion of Foxa2 in the lung (21) .
Deletion of Both Foxa1 and Foxa2 Inhibits Branching Morphogenesis of the Lung-At the light microscopic level, lung morphology was similar in Foxa1
Ϫ/Ϫ (Fig. 1, D, F , and J), Foxa2 ⌬/⌬ (Fig. 1 , C, G, and K), and control mice (Fig. 1, A , E, and I) at E12.5, E15.5, and E18.5. At E12.5, branching of lung tubules was similar in mice of each genotype (Fig. 1, A-D) . However, by E15.5 enlarged tubules were readily observed at sites in which both Foxa1 and Foxa2 were deleted (Fig. 1H) . At E18.5, enlarged cystic bronchial tubules were noted in the lungs of Foxa1 Ϫ/Ϫ /Foxa2 ⌬/⌬ mice. Small terminal lung saccules typical of the normal lung at E18.5 failed to form in the regions lacking both Foxa1 and Foxa2. Lung morphology was maintained in the regions of the lung parenchyma in which Foxa2 staining was present (Fig. 1, I-L) . The sites and extent of lung malformation correlated well with the sites and extent of the deletion of Foxa1 and Foxa2.
To assess the effect of deletion of both Foxa1 and Foxa2 on branching morphogenesis, lungs from control and Foxa1 Ϫ/Ϫ / Foxa2 ⌬/⌬ mice were excised and imaged at E12.5, E13.5, E14.5, and E18.5. Differences in the extent of branching were observed in Foxa1 Ϫ/Ϫ /Foxa2 ⌬/⌬ mice as early as E12.5 and, thereafter, less branching was detected in the lungs of Foxa1 Ϫ/Ϫ / Foxa2 ⌬/⌬ mice as compared with controls ( Fig. 3, A 
-H). Lobulation was not disturbed in the Foxa1
Ϫ/Ϫ /Foxa2 ⌬/⌬ mice. Abnormal dilated peripheral tubules were observed as early as E13.5 (Fig. 3B) . Lungs of Foxa1 Ϫ/Ϫ /Foxa2 ⌬/⌬ mice were visibly smaller than those from Foxa1 Ϫ/Ϫ , Foxa2 ⌬/⌬ (Fig. 3 , B, D, F, and H), and controls (Fig. 3, A, C mice at E18.5 were glycogen rich but lacked the microvilli, cilia, and granules typical of various fully differentiated cell types seen in the control mice (Fig. 4) . In control mice, squamous type I and cuboidal type II cells (the latter with lamellar bodies) were observed throughout the peripheral regions of the lungs. Ciliated and non-ciliated columnar epithelial cells were observed in the conducting airways of control litter mates. At E15.5, the respiratory epithelium of both control and cells seen in normal mice at E15.5 (Fig. 4) . The pulmonary vascular bed was intact, and there was no evidence of hemorrhage. PECAM staining demonstrated that the lungs of Foxa1 Ϫ/Ϫ /Foxa2 ⌬/⌬ mice were well vascularized (see supplemental Fig. 1 in the on-line version of this article).
To assess whether deletion of Foxa1 and Foxa2 altered expression of differentiation markers, serial sections were immunostained for proSP-C, SP-B, and TTF1 at E18.5 and correlated with sites of Foxa2 deletion. Although TTF1 staining was not altered following deletion of both Foxa1 and Foxa2 (Fig. 5, E  and F) , SP-B and pro-SPC staining was absent. Cells lacking SP-B and proSP-C were correlated with the absence of Foxa2 staining in the Foxa1 Ϫ/Ϫ /Foxa2 ⌬/⌬ mice (Fig. 5, C and D) , supporting a cell autonomous role for the Foxa proteins in epithelial cell differentiation. Likewise, staining for CCSP and Foxj1 was absent in conducting airway epithelial cells lacking both Foxa1 and Foxa2 (Fig. 6) . Thus, Foxa1 and Foxa2 are required for the expression of epithelial cell differentiation markers typical of normal peripheral and conducting airways.
Deletion of Foxa1 and Foxa2 Affects Cell ProliferationLungs of Foxa1
Ϫ/Ϫ /Foxa2 ⌬/⌬ mice were visibly smaller than those of control mice. To discern whether the deletion of Foxa1 and Foxa2 altered cell proliferation, serial sections of lung tissue were stained for ␣-phosphohistone H3 and Foxa2 (see supplemental Fig. 2 in the on-line version of this article) at E15.5. The number of cells stained for ␣-phosphohistone H3 was significantly decreased in the lungs of Foxa1 Ϫ/Ϫ /Foxa2 ⌬/⌬ mice as compared with controls (p Ͻ 0.05). In serial sections, ␣-phosphohistone H3 staining was observed in epithelial cells that lacked both Foxa1 and Foxa2 staining, indicating their mitotic activity. In addition, there was no evidence of cell death, nuclear fragmentation, or abnormal mitotic activity in the respiratory epithelium after the deletion of Foxa1 and Foxa2 as assessed by light and electron microscopy at E15.5 and E18.5 ( Fig. 4 and data (Fig. 7A) , indicating that the normal pattern of Shh expression was dependent on the presence of Foxa family members. Likewise, the content of Shh mRNA was significantly decreased at E14.5 (Fig. 7C) . ␣-SMA, a smooth muscle cell marker and known Shh target, is normally expressed in the smooth muscle cells around the bronchi and bronchioles of the developing lung. Consistent with previous data showing that ␣-SMA is absent in the peripheral lung mesenchyme in Shh Ϫ/Ϫ mice (28, 32), ␣-SMA immunostaining of lungs from Foxa1 Ϫ/Ϫ /Foxa2 ⌬/⌬ mice demonstrated that ␣-SMA was decreased or absent around bronchioles lacking Foxa1 and Foxa2. Thus, the combined deletion of Foxa1 and Foxa2 inhibited mesenchymal smooth muscle cell differentiation, consistent with the decreased expression of Shh (Fig. 7, E-G) . Consistent with the observed decreased Shh expression, the hedgehog-interacting protein (Hhip), myocardin (Myocd), and a number of mRNAs related to smooth muscle cell differentiation were decreased in the Foxa1 Ϫ/Ϫ /Foxa2 ⌬/⌬ mice at E14.5, including thrombospodin 3 (Thbs3), calponin 1 (Cnn1), myosin heavy polypeptide 11 (Myh11), myosin light polypeptide 9 (Myl9), smooth muscle enteric actin ␥2 (Actg2), and the actin-associated protein transgelin (SM22␣ or Tagln) ( Table I ). Foxa1 and Foxa2 immunostaining was assessed in lungs from Shh Ϫ/Ϫ mice. Nuclear staining for Foxa1 and Foxa2 was observed in the epithelial cells of respiratory tubules in Shh Ϫ/Ϫ mice at E18.5, demonstrating that Shh is not required for the expression of Foxa proteins in the lung (data not shown). Wnt7b mRNA was significantly decreased (Fig. 7D) , which is perhaps consistent with previous studies demonstrating that Foxa2 regulated Wnt7b gene transcription in vitro (33) . DISCUSSION The formation of the fetal lung occurs by a process of branching morphogenesis and depends upon complex paracrine signaling between the epithelium and the mesenchyme that in turn controls transcriptional programs regulating cell behavior during development. In the present study, branching and epithelial cell differentiation were perturbed after the deletion of Foxa1 and Foxa2 in lung epithelial cells, indicating that Foxa transcription factors are required for lung morphogenesis and function. Deletion of Foxa1 and Foxa2 activity inhibited the expression of Shh and Wnt7b, providing potential mechanisms by which the lack of Foxa1 and Foxa2 activity influences branching morphogenesis and differentiation of the lung.
Foxa1 and Foxa2 Play Redundant Roles During Branching Morphogenesis of the Fetal Lung-Expression of Foxa1 and
Foxa2 is first detected at the onset of lung bud formation. Thereafter, Foxa1 and Foxa2 are expressed in a similar temporal-spatial pattern in the respiratory epithelial cells of the conducting and peripheral airways (13) . Branching morphogenesis was not perturbed in single knock-out Foxa1 Ϫ/Ϫ or Foxa2 ⌬/⌬ mice. In the Foxa1 Ϫ/Ϫ /Foxa2 ⌬/⌬ mice, formation of small peripheral acinar tubules and terminal saccules was markedly disrupted in regions where deletion of both Foxa1 and Foxa2 had occurred, supporting the hypothesis that the transcription factors Foxa1 and Foxa2 act in a complementary manner during branching morphogenesis.
The timing and extent of recombination with the SP-C-rtTA/ tetO 7 Cre system were variable and dependent upon the varying efficiency of targeted recombination of each floxed gene (21, 34) . Gene targeting occurs in epithelial cells throughout the pulmonary parenchyma and occurs during early lung morphogenesis in the SP-C-rtTA mice (34) . The extent of loss of Foxa2 staining in Foxa1 Ϫ/Ϫ /Foxa2 ⌬/⌬ mice was less than in the Foxa2 ⌬/⌬ mice in the Foxa1 ϩ/ϩ background, indicating that the lack of Foxa1 may decrease the efficiency of targeting directed by the SP-C-rtTA, (tetO) 7 Cre system. In this mouse model, 
FIG. 4. Lung ultrastructure in Foxa1
؊/؊ /Foxa2 ⌬/⌬ mice. Electron microscopy was performed on lungs from Foxa1 Ϫ/Ϫ /Foxa2 ⌬/⌬ mice (B) and control litter mates (A) observed at E18.5. Squamous type I cells (thick arrow) and cuboidal type II cells (arrowhead) containing lamellar bodies, apical microvilli, and highly organized rosette glycogen were observed in lungs of control mice (A). The densely stained cell below the type I cell is a capillary endothelial cell creating the gas exchange area (A). Type I cells were not observed in lung of Foxa2 ⌬/⌬ mice (B). The pulmonary vascular bed in Foxa1 Ϫ/Ϫ /Foxa2 ⌬/⌬ mice was intact, but in the absence of type I cells the thin walled alveolar-capillary interface seen in the control mice was not formed. Type II cells were immature. Lamellar bodies were absent and apical microvilli were sparse in
abnormalities in branching and cell differentiation correlated with the extent of deletion of both Foxa1 and Foxa2. Branching morphogenesis of the lung requires precise signaling from both epithelial and mesenchymal compartments to regulate cell proliferation, migration, and subsequent lungspecific gene expression. Many genes and associated signaling pathways influence the process of branching morphogenesis, including ␤-catenin, Rar/Rxr, Tgf␤, Shh, Fgf10, and Bmp4 (1, 3, (35) (36) (37) (38) . Although the mechanisms by which Foxa1 and Foxa2 regulate branching morphogenesis are not understood completely, Foxa1 and Foxa2 have been implicated in several of these pathways. Foxa2 regulates Shh during early embryogenesis and central nervous system formation (39) . Foxa2 positively regulated Shh transcription within the central nervous system and the axial mesoderm. Foxa1, Foxa2, and Shh are co-expressed in subsets of epithelial cell during early lung morphogenesis (39 -43) . In the present study, decreased or absent Shh mRNA was observed after the deletion of and control litter mates were prepared on E15.5 and immunostained for ␣-SMA. In controls (E), ␣-SMA was detected in the smooth muscle cells around the bronchioles (arrowhead). In Foxa1 Ϫ/Ϫ /Foxa2 ⌬/⌬ mice (F), ␣-SMA was decreased or absent around the bronchioles (arrow). Serial sections were used for Foxa2 immunostaining to demonstrate the sites of deletion of Foxa1 and Foxa2. Scale bar (black), 100 m.
caused lung hypoplasia associated with defects in smooth muscle in the major pulmonary vessels (44) . These findings are consistent with the present observations in Foxa1
mice, indicating that effects of their deletion may be, in part, mediated by altered Wnt7b signaling. Consistent with these in vitro studies, Wnt7b mRNA was significantly decreased in the lung of Foxa1 Ϫ/Ϫ /Foxa2 ⌬/⌬ mice. Thus, Foxa1 and Foxa2 are required for the precise expression of Wnt7b that, in turn, may influence ␤-catenin-dependent signaling to influence lung morphogenesis or cell differentiation (33) . Mechanisms by which Foxa1 and Foxa2 influence epithelial cell differentiation during lung morphogenesis are likely complex and remain to be identified.
Pulmonary Epithelial Cell Differentiation Depends Upon Foxa Transcription Factors-Foxa transcription factors were shown previously to regulate cell differentiation in many organs, including the lung, central nervous system, pancreas, and liver (20, 21, (45) (46) (47) (48) . Targeted disruption of Foxa2 in the mouse lung inhibited maturation of type II cells and caused goblet cell hyperplasia in the conducting airways, suggesting an important role of Foxa2 in the regulation of epithelial cell differentiation and function in both conducting airways and alveoli. Expression of epithelial cell markers, including SP-A, SP-B, and CCSP, was decreased, but their expression was not entirely dependent on Foxa2 (21) . In contrast, immunostaining for the epithelial cell differentiation markers, SP-B, SP-C, CCSP, and Foxj1 was absent in the relatively immature columnar and cuboidal cells lining the enlarged tubules in the (21, 52, 53) . A number of genes that are expressed in the lung are regulated by both Foxa1 and Foxa2, including Sftpb (51), Scgbla1 (52, 53) , lysozyme M, and lysozyme P (54). However, the distinct phenotypes in Foxa1 Ϫ/Ϫ and Foxa2 ⌬/⌬ mice (21-23) and the distinct expression patterns of Foxa1 and Foxa2 in many organs (13) suggest that Foxa1 and Foxa2 may also differentially regulate gene expression during embryogenesis and lung development.
Foxa1 and Foxa2 may regulate gene transcription directly or indirectly by stabilizing nucleosome positioning (55, 56) . Foxa also modulates gene expression by interacting with other transcription factors, including SP1, the CCAAT/enhancer-binding protein, and the retinoic acid receptor/retinoid X receptor (57) (58) (59) . Foxa1 and Foxa2 are co-expressed with TF1 and share transcriptional targets in the respiratory epithelium (54, 60) . It is therefore likely that other transcription factors interact and cooperate with Foxa1 and Foxa2 in a complex transcriptional program that regulates gene expression in the developing lung. Foxa1 mRNA was induced after the deletion of Foxa2 in respiratory epithelial cells. Likewise, Foxa2 mRNA was increased in lungs of Foxa1 Ϫ/Ϫ mice, supporting the concept that these Foxa family members play complementary roles in the regulation of branching morphogenesis and the expression of genes required in lung function after birth. Foxa proteins are utilized recurrently and at discrete times during foregut differentiation. Foxa expression is required for A-P axis formation in the early embryo, branching morphogenesis, epithelial cell differentiation prior to birth, and epithelial cell function in the postnatal lung. 
